Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 27.24% ...

Iovance Biotherapeutics Inc (IOVA) stock saw a modest uptick, ending the day at $5.99 which represents a slight increase of $0.11 or 1.87% from the prior close of $5.88. The stock opened at $5.9 and ...

Intel (NASDAQ:INTC – Get Free Report) had its target price decreased by research analysts at UBS Group from $26.00 to $23.00 ...

Heidelberg Materials (0MG2 – Research Report) received a Hold rating and a €135.00 price target from Barclays analyst Tom Zhang today. The ...

Barclays analyst Wendy Liu, CFA maintained a Hold rating on PUMA SE NPV (PMMAF – Research Report) today and set a price target of €45.00. The ...

UBS and Barclays have fairly similar capacities — around 17,000 seats for sports games and 19,000 for concerts. But UBS is brand-new, having opened in 2021, and PBR said it offers expanded capacity, ...

We've identified the following companies as similar to UBS Barclays US Liquid Corporates UCITS hedged to EUR A-acc because they operate in a related industry or sector. We also considered size, growth ...

UBS upgraded Dana Holding (NYSE:DAN) stock from Neutral to Buy, significantly raising the price target from $11.00 to $18.00. The upgrade comes with a positive outlook on the company's financial ...

Eiichiro Yoshida from Nissay Asset Management Corp. and Hiroaki Sato from Barclays Plc also started at UBS Securities Japan Co. on the same day.

UBS increased their price target for JPMorgan shares, listed on the New York Stock Exchange (NYSE:JPM), to $287 from the ...

Eiichiro Yoshida from Nissay Asset Management Corp. and Hiroaki Sato from Barclays Plc also started at UBS Securities Japan Co. on the same day. “This investment in broadening our reach ...